LeonaBio, Inc. Increase Decrease In Operating Lease Liability
LeonaBio, Inc. (LONA) reported Increase Decrease In Operating Lease Liability of -$226.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- LeonaBio, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$114.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$112.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$109.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$105.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for fiscal 2025 was -$414.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for fiscal 2024 was -$368.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for fiscal 2023 was -$326.00K.
- LeonaBio, Inc. increase decrease in operating lease liability for fiscal 2022 was -$15.00K, a 106.22% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$226.00K 10-Q · filed 2026-08-14 | -$335.00K derived: sum of 3 quarters · filed 2026-08-14 | -$440.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$112.00K 10-Q · filed 2026-05-07 | -$221.00K derived: sum of 2 quarters · filed 2026-05-07 | -$326.00K derived: sum of 3 quarters · filed 2026-05-07 | -$426.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$214.00K derived: sum of 2 quarters · filed 2026-03-31 | -$314.00K derived: sum of 3 quarters · filed 2026-08-14 | -$414.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$205.00K derived: sum of 2 quarters · filed 2026-08-14 | -$305.00K 10-Q · filed 2025-11-06 | -$402.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$200.00K 10-Q · filed 2026-08-14 | -$297.00K derived: sum of 3 quarters · filed 2026-08-14 | -$390.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-07 | -$197.00K derived: sum of 2 quarters · filed 2026-05-07 | -$290.00K derived: sum of 3 quarters · filed 2026-05-07 | -$381.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$190.00K derived: sum of 2 quarters · filed 2026-03-31 | -$281.00K derived: sum of 3 quarters · filed 2026-03-31 | -$368.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$184.00K derived: sum of 2 quarters · filed 2025-11-06 | -$271.00K 10-Q · filed 2025-11-06 | -$358.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$178.00K 10-Q · filed 2025-08-07 | -$265.00K derived: sum of 3 quarters · filed 2025-08-07 | -$347.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$87.00K 10-Q · filed 2025-05-09 | -$174.00K derived: sum of 2 quarters · filed 2025-05-09 | -$256.00K derived: sum of 3 quarters · filed 2025-05-09 | -$336.00K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$169.00K derived: sum of 2 quarters · filed 2025-02-27 | -$249.00K derived: sum of 3 quarters · filed 2025-02-27 | -$326.00K 10-K · filed 2025-02-27 | |||
| 2023-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$162.00K derived: sum of 2 quarters · filed 2024-11-07 | -$239.00K 10-Q · filed 2024-11-07 | -$42.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$157.00K 10-Q · filed 2024-08-01 | $40.00K derived: sum of 3 quarters · filed 2024-08-01 | -$33.00K derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-03-31 | -$77.00K 10-Q · filed 2024-05-15 | $120.00K derived: sum of 2 quarters · filed 2024-05-15 | $47.00K derived: sum of 3 quarters · filed 2024-05-15 | -$23.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $124.00K derived: sum of 2 quarters · filed 2024-02-22 | $54.00K derived: sum of 3 quarters · filed 2024-02-22 | -$15.00K 10-K · filed 2024-02-22 | |||
| 2022-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$143.00K derived: sum of 2 quarters · filed 2023-11-09 | -$212.00K 10-Q · filed 2023-11-09 | -$279.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$139.00K 10-Q · filed 2023-08-10 | -$206.00K derived: sum of 3 quarters · filed 2023-08-10 | -$263.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$69.00K 10-Q · filed 2023-05-11 | -$136.00K derived: sum of 2 quarters · filed 2023-05-11 | -$193.00K derived: sum of 3 quarters · filed 2023-05-11 | -$210.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$124.00K derived: sum of 2 quarters · filed 2023-03-23 | -$141.00K derived: sum of 3 quarters · filed 2023-03-23 | $241.00K 10-K · filed 2023-03-23 | $396.00K 10-K · filed 2022-03-28 | ||
| 2021-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$74.00K derived: sum of 2 quarters · filed 2022-11-10 | $308.00K 10-Q · filed 2022-11-10 | $419.00K 10-Q · filed 2021-11-10 | $359.00K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $365.00K 10-Q · filed 2022-08-15 | $433.00K 10-Q · filed 2021-08-16 | $416.00K derived: sum of 3 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $382.00K 10-Q · filed 2022-05-12 | $433.00K derived: sum of 2 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $64.00K 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | $13.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |